Benefit from anti-inflammatory treatment during clinical remission of atopic asthma

Respiratory Medicine

Volumn 99, Issue 6, 2005, Pages 779-787

  van den Toorn, Leon M ^a   Prins, Jan Bas ^a   de Jongste, Johan C ^a   Leman, Karolina ^a   Mulder, Paul G H ^a   Hoogsteden, Henk C ^a   Overbeek, Shelley E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; Bronchial hyperresponsiveness; Eosinophils; Exhaled nitric oxide; Fluticasone; Inflammation; Mast cells; Remission; Remodeling; Salmeterol

Indexed keywords

ADENOSINE PHOSPHATE; ANTIINFLAMMATORY AGENT; BRICANYL TURBOHALER; CHYMASE; FLUTICASONE PROPIONATE PLUS SALMETEROL; MAJOR BASIC PROTEIN; METHACHOLINE; NITRIC OXIDE; PLACEBO; TERBUTALINE; TRYPTASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG RESPONSE; EOSINOPHIL; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOHISTOCHEMISTRY; INHALER; LONG TERM CARE; LUNG FUNCTION TEST; MALE; MAST CELL; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SIDE EFFECT; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ALBUTEROL; ANALYSIS OF VARIANCE; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; BRONCHOSCOPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 18244410391     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.11.011     Document Type: Article

References (38)

1. R.A. Barbee S. Murphy The natural history of asthma J Allergy Clin Immunol 102 1998 S65-S72
2. C.I. Panhuysen J.M. Vonk G.H. Koeter et al. Adult patients may outgrow their asthma: A 25-year follow-up study Am J Respir Crit Care Med 155 1997 1267-1272
3. L.M. Van den Toorn S.E. Overbeek J.C. De Jongste et al. Airway inflammation is present during clinical remission of atopic asthma Am J Respir Crit Care Med 164 2001 2107-2113
4. T.J. Warke P.S. Fitch V. Brown et al. Outgrown asthma does not mean no airways inflammation Eur Respir J 19 2002 284-287
5. A.M. Vignola R. Gagliardo A. Siena et al. Airway remodeling in the pathogenesis of asthma Curr Allergy Asthma Rep 1 2001 108-115
6. P.J. Barnes Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma J Allergy Clin Immunol 101 1998 S427-S433
7. H.A. Boushey Effects of inhaled corticosteroids on the consequences of asthma J Allergy Clin Immunol 102 1998 S5-S16
8. N.J. Vanacker E. Palmans J.C. Kips et al. Fluticasone inhibits but does not reverse allergen-induced structural airway changes Am J Respir Crit Care Med 163 2001 674-679
9. M. Hoshino M. Takahashi Y. Takai et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma J Allergy Clin Immunol 104 1999 356-363
10. B.E. Orsida C. Ward X. Li et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma Am J Respir Crit Care Med 164 2001 117-121
11. C. Ward M. Pais R. Bish et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax 57 2002 309-316
12. J. De Kluijver C.E. Evertse J.A. Schrumpf et al. Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids Am J Respir Crit Care Med 166 2002 294-300
13. A. Laitinen A. Altraja M. Kampe et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid Am J Respir Crit Care Med 156 1997 951-958
14. J.V. Fahy D.B. Corry H.A. Boushey Airway inflammation and remodeling in asthma Curr Opin Pulm Med 6 2000 15-20
15. P.K. Jeffery P. Venge M.J. Gizycki et al. Effects of salmeterol on mucosal inflammation in asthma: A placebo-controlled study Eur Respir J 20 2002 1378-1385
16. X. Li C. Ward F. Thien et al. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma Am J Respir Crit Care Med 160 1999 1493-1499
17. A. Wallin T. Sandstrom M. Soderberg et al. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma Am J Respir Crit Care Med 159 1999 79-86
18. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 1987 225-244
19. G. Rosati F.E. Hargreave E.H. Ramsdale Inhalation of adenosine 5′-monophosphate increases methacholine airway responsiveness J Appl Physiol 67 1989 792-796
20. L.M. Van den Toorn J.B. Prins S.E. Overbeek et al. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness Am J Respir Crit Care Med 162 2000 953-957
21. D. Birnie G.W. thoe Schwartzenberg W.C. Hop et al. Does the outcome of the tidal breathing and dosimeter methods of assessing bronchial responsiveness in children with asthma depend on age? Thorax 45 1990 199-202
22. S. Kharitonov K. Alving P.J. Barnes Exhaled and nasal nitric oxide measurements: Recommendations. The European respiratory society task force Eur Respir J 10 1997 1683-1693
23. P. Sullivan D. Stephens T. Ansari et al. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies Eur Respir J 12 1998 811-815
24. R.H. Brook J.E. Ware Jr A. Davies-Avery et al. Overview of adult health measures fielded in Rand's health insurance study Med Care 17 3-10 1979 1-131
25. J. Van Schoor G.F. Joos R.A. Pauwels Indirect bronchial hyperresponsiveness in asthma: Mechanisms, pharmacology and implications for clinical research Eur Respir J 16 2000 514-533
26. M. Van den Berge H.A. Kerstjens R.J. Meijer et al. Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine Am J Respir Crit Care Med 164 2001 1127-1132
27. Y.Y. Koh Y.H. Sun H.S. Lim et al. Effect of inhaled budesonide on bronchial hyperresponsiveness in adolescents with clinical remission of asthma Chest 120 2001 1140-1146
28. D.N. Payne I.M. Adcock N.M. Wilson et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone Am J Respir Crit Care Med 164 2001 1376-1381
29. T.J. Warke P.S. Fitch V. Brown et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma Thorax 57 2002 383-387
30. J. Mattes K. Storm van's Gravesande U. Reining et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma Eur Respir J 13 1999 1391-1395
31. S. Lim A. Jatakanon S. Meah et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma Thorax 55 2000 184-188
32. G.L. Colice Categorizing asthma severity and monitoring control of chronic asthma Curr Opin Pulm Med 8 2002 4-8
33. S.A. Kharitonov P.J. Barnes Clinical aspects of exhaled nitric oxide Eur Respir J 16 2000 781-792
34. E.L. van Rensen K.C. Straathof M.A. Veselic-Charvat et al. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma Thorax 54 1999 403-408
35. S. Page A.J. Ammit J.L. Black et al. Human mast cell and airway smooth muscle cell interactions implications for asthma Am J Physiol Lung Cell Mol Physiol 281 2001 L1313-L1323
36. C.P. Sommerhoff Mast cell tryptases and airway remodeling Am J Respir Crit Care Med 164 2001 S52-S58
37. D.M. McDonald Angiogenesis and remodeling of airway vasculature in chronic inflammation Am J Respir Crit Care Med 164 2001 S39-S45
38. M. Johnson The anti-inflammatory profile of fluticasone propionate Allergy 50 1995 11-14